UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Trims Holdings in Anterix Inc. (NASDAQ:ATEX)

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC lowered its holdings in shares of Anterix Inc. (NASDAQ:ATEXFree Report) by 7.9% in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 22,542 shares of the company’s stock after selling 1,931 shares during the period. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC owned 0.12% of Anterix worth $849,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors also recently bought and sold shares of the business. Allspring Global Investments Holdings LLC acquired a new stake in shares of Anterix during the second quarter worth about $28,000. nVerses Capital LLC acquired a new stake in Anterix during the 3rd quarter worth approximately $45,000. Meeder Asset Management Inc. purchased a new position in shares of Anterix in the 3rd quarter valued at approximately $58,000. Point72 Asia Singapore Pte. Ltd. acquired a new position in shares of Anterix in the second quarter valued at approximately $92,000. Finally, Jupiter Asset Management Ltd. purchased a new stake in shares of Anterix during the second quarter worth approximately $200,000. 87.67% of the stock is owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

Separately, Craig Hallum upgraded shares of Anterix to a “strong-buy” rating in a research report on Wednesday, October 9th.

View Our Latest Stock Analysis on Anterix

Insider Activity

In related news, Director Leslie B. Daniels purchased 2,000 shares of Anterix stock in a transaction dated Wednesday, November 20th. The stock was bought at an average cost of $32.75 per share, for a total transaction of $65,500.00. Following the transaction, the director now owns 2,000 shares in the company, valued at approximately $65,500. The trade was a ∞ increase in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, Director Mark Fleischhauer purchased 3,500 shares of the firm’s stock in a transaction dated Thursday, December 5th. The shares were purchased at an average cost of $34.19 per share, for a total transaction of $119,665.00. Following the purchase, the director now directly owns 3,500 shares in the company, valued at approximately $119,665. This represents a ∞ increase in their ownership of the stock. The disclosure for this purchase can be found here. Insiders own 45.61% of the company’s stock.

Anterix Stock Up 1.4 %

Shares of NASDAQ:ATEX opened at $30.47 on Friday. Anterix Inc. has a 52 week low of $29.12 and a 52 week high of $42.41. The company has a 50-day moving average price of $33.28 and a 200 day moving average price of $35.62. The company has a market cap of $567.29 million, a P/E ratio of -15.08 and a beta of 0.85.

About Anterix

(Free Report)

Anterix Inc operates as a wireless communications company. The company focuses on commercializing its spectrum assets to enable the targeted utility and critical infrastructure customers to deploy private broadband networks and innovative broadband solutions. It holds licensed spectrum in the 900 MHz band with coverage throughout the United States, Alaska, Hawaii, and Puerto Rico.

Featured Stories

Institutional Ownership by Quarter for Anterix (NASDAQ:ATEX)

Receive News & Ratings for Anterix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Anterix and related companies with MarketBeat.com's FREE daily email newsletter.